Riskpilot← Back to searchSign inGet full accessDEVOMEDIC ApS
APSActiveCVR 33595085Ålykkegade 13Engineering activities and related technical consultancy · NACE 7112Est. 20113 employees
Revenue 2024
DKK 1,9M
+87% vs 2023
EBITDA margin
24.6%
+155% vs 2023
Equity ratio
34.9%
Financial strength
Net profit 2024
DKK 172K
+472% vs 2023
| Revenue | DKK 1,9M | +87% |
| EBITDA | DKK 456K | +155% |
| Net profit | DKK 172K | +472% |
| Total assets | DKK 4,3M | -3% |
| Equity | DKK 1,5M | +13% |
| Employees | 3 | — |
Legal name
DEVOMEDIC ApS
CVR number
33595085
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
11. april 2011
Share capital
DKK 80.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er at eje kapitalandele i andre virksomheder, at drive investeringsvirksomhed, at virke som holdingselskab samt al virksomhed, som efter direktionens skøn er beslægtet hermed.
Address
Ålykkegade 13
Email
info@devomedic.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 500 | 895 | 952 | 991 | 1.858 |
| Staff expenses | -376 | -313 | -337 | -813 | -1.401 |
| EBITDA | 124 | 582 | 614 | 179 | 456 |
| Depreciation & amort. | -14 | -47 | -71 | -75 | -73 |
| EBIT | 110 | 534 | 544 | 104 | 384 |
| Net financials | 3 | -51 | -93 | -146 | -155 |
| Profit before tax | 113 | 483 | 451 | -41 | 229 |
| Tax | 27 | 116 | 118 | 5 | 57 |
| Net profit | 87 | 367 | 333 | -46 | 172 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.072 | 4.031 | 4.269 | 4.458 | 4.344 |
| Equity | 807 | 1.174 | 1.450 | 1.344 | 1.516 |
| Long-term debt | 0 | 2.500 | 2.500 | 2.500 | 1.950 |
| Short-term debt | 265 | 357 | 313 | 613 | 878 |
| Total debt | 265 | 2.857 | 2.813 | 3.113 | 2.828 |
EBITDA margin
24.6%
This company
15.8%
Market median
+56% vs market
20202024
Equity ratio
34.9%
This company
38.2%
Market median
+9% vs market
20202024
Return on equity
11.3%
This company
18.4%
Market median
+39% vs market
20202024
Net profit margin
9.3%
This company
8.1%
Market median
+15% vs market
20202024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20202024
Debt / equity
1.86×
This company
0.62×
Market median
-200% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JP Chief Executive Officer | Chief Executive Officer | 2014 – 2017 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2024 | |
| Individual | 100% | 100% | 2014 | |
| Individual | 100% | 100% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DEVOMEDIC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Palle | Chief Executive Officer | 0 companies |